At HBOT USA, combining hyperbaric oxygen therapy (HBOT) with other wellness and performance therapies is a topic that comes up frequently. HBOT can be incorporated into a broader wellness strategy, but that does not mean every therapy should be performed at the same time or brought into the hyperbaric chamber. In some cases, the issue is simply timing. In others, combining modalities may change the physiological response you are trying to achieve. Most importantly, some devices, products, medications, and materials may not be appropriate inside a hyperbaric environment. The FDA has emphasized that hyperbaric facilities must follow manufacturer instructions, maintain fire prevention procedures, properly train staff, and control what enters the chamber.
If you use HBOT yourself or operate a hyperbaric clinic, understanding how to sequence different therapies can make a major difference. The goal is not to avoid every other modality. Instead, it is to understand which therapies can potentially complement HBOT, which should be separated, and which should never be brought into the chamber unless specifically approved.
Why Combining Therapies Requires Care
There is growing interest in combining different technologies to support wellness, exercise recovery, cognitive performance, and other health goals.
You may see protocols involving HBOT alongside red light therapy, PEMF, hydrogen, IV therapy, carbon dioxide exposure, ozone, or other modalities.
The idea behind combining therapies is understandable. If two approaches influence different physiological pathways, using them together might appear to offer an opportunity for greater results.
But HBOT is different from many other wellness technologies.
During HBOT, a person is exposed to elevated pressure while breathing a high concentration of oxygen. Oxygen itself has physiological effects, and the hyperbaric environment introduces additional safety considerations.
The Undersea & Hyperbaric Medical Society describes HBOT as an intervention involving near 100% medical oxygen at pressure above normal atmospheric pressure.
That means the hyperbaric chamber should never be treated like an ordinary wellness room.
Anything brought inside must be evaluated for compatibility with the chamber and the specific environment.
1. Hydrogen Therapy: Think About Timing
Molecular hydrogen has attracted considerable interest in wellness circles because of its potential effects on oxidative and cellular signaling pathways.
Hydrogen may be delivered through hydrogen-rich water, inhalation systems, or other specialized approaches.
The important question when combining hydrogen with HBOT is not simply whether hydrogen is “good” or “bad.”
It is about understanding what each therapy is intended to accomplish and whether performing them simultaneously makes sense.
HBOT increases oxygen availability and can influence oxidative signaling. Hydrogen is commonly discussed in connection with redox biology and oxidative stress.
Because these therapies interact with related physiological pathways, some practitioners prefer to separate them rather than automatically stacking them at the exact same time.
This is an area where sequencing matters.
If hydrogen is part of a person’s wellness protocol, the practitioner should determine whether it makes more sense before or after HBOT based on the individual’s goals, medical history, and the specific hydrogen delivery system being used.
Most importantly, a hydrogen device should not automatically be taken into a hyperbaric chamber.
The fact that a device is safe in an ordinary room does not mean it is safe in an oxygen-enriched or pressurized environment.
2. IV Therapy: Don’t Assume It Belongs in the Chamber
IV therapy is another modality that people sometimes want to combine with HBOT.
There can be practical reasons for doing both during the same appointment. However, having an IV does not automatically mean that the infusion equipment should be inside the chamber.
Hyperbaric facilities have specific requirements concerning equipment and materials that can enter the chamber.
UHMS guidance notes that hyperbaric medical directors and safety directors are responsible for evaluating items and equipment used within the hyperbaric environment.
This becomes especially important with:
- IV pumps
- Electronic monitoring equipment
- Infusion systems
- Tubing and connections
- Medication containers
- Batteries and electrical devices
The safest approach is not to assume compatibility.
Instead, the hyperbaric team should verify that the specific equipment has been evaluated and approved for the chamber being used.
There is also another consideration: medications themselves.
HBOT can interact with certain medications, and the hyperbaric physician should review changes to medications as part of patient screening. Some medications may influence susceptibility to oxygen toxicity or have other considerations in the hyperbaric environment.
So if a patient is receiving IV therapy, the question is not simply, “Can we do an IV and HBOT on the same day?”
The better questions are:
What is being infused?
When should it be administered?
Is the equipment chamber compatible?
Does the medication have any hyperbaric considerations?
3. Carbon Dioxide Therapy: Don’t Automatically Stack It
Carbon dioxide therapy is another modality that can raise questions when used alongside HBOT.
CO2 plays an important role in human physiology and is involved in blood vessel regulation and respiratory physiology. However, intentionally manipulating carbon dioxide exposure is very different from normal breathing.
HBOT, meanwhile, changes oxygen availability through increased pressure and oxygen concentration.
Because both oxygen and carbon dioxide can influence vascular and respiratory physiology, sequencing may be preferable to automatically performing both interventions simultaneously.
The appropriate order and timing depend on the specific CO2 modality, concentration, duration, equipment, and patient.
For a clinic, this means there should be a defined protocol rather than simply putting two therapies together because they are available.
4. Red Light Therapy: Potentially Complementary, But Timing Still Matters
Red light therapy and near-infrared light therapy are frequently discussed alongside HBOT.
Both modalities are associated with interest in cellular signaling and mitochondrial function, which makes the combination particularly interesting from a theoretical standpoint.
But “potentially complementary” does not mean “always better when performed simultaneously.”
When combining therapies, more is not necessarily better.
A clinic may choose to perform red light therapy before or after HBOT depending on the protocol and intended goal.
The key is to understand what each modality is doing rather than assuming that stacking everything together automatically creates a stronger effect.
There is also an important distinction between using a red light device outside the chamber and attempting to bring that device inside.
A red light panel that is perfectly safe in a normal management room may not be approved for use in a hyperbaric chamber.
Electrical equipment, batteries, cords, plastics, fabrics, and other materials can create additional fire or static risks in an oxygen-rich environment.
The FDA specifically advises facilities to follow manufacturer instructions and avoid prohibited or static-generating items inside HBOT devices.
5. PEMF: Keep the Equipment Outside Unless Approved
Pulsed electromagnetic field therapy, commonly called PEMF, is another modality sometimes combined with HBOT.
PEMF systems use electromagnetic fields generated by specialized equipment.
Whether PEMF and HBOT can be used during the same overall wellness program is a separate question from whether a PEMF device can be operated inside the chamber.
The second question is much more important from a safety perspective.
Never assume that a device is chamber-compatible simply because it does not appear to generate heat or an obvious ignition source.
The hyperbaric environment has specific requirements concerning electrical and electronic equipment.
UHMS safety guidance emphasizes that the medical and safety leadership of the facility has responsibility for determining whether particular devices and materials can safely enter the chamber.
For that reason, PEMF is generally something to evaluate as a separate session or separately sequenced modality, unless the specific equipment has been appropriately evaluated and approved for use in that hyperbaric environment.
6. Methylene Blue: Review It With the Medical Team
Methylene blue is sometimes discussed in biohacking and mitochondrial wellness conversations, including in combination with light-based approaches and oxygen-related protocols.
However, methylene blue is not something to casually add to an HBOT protocol without considering the person’s medical situation.
Methylene blue can have clinically important drug interactions and is not appropriate for everyone.
This is a good example of why “stacking” therapies should not simply mean taking multiple interventions because they appear complementary.
If a patient uses methylene blue, supplements, prescription medications, or other compounds, the hyperbaric medical team should know about them.
The UHMS position on physician responsibilities includes reviewing new medications and evaluating potential interactions with the hyperbaric environment.
In other words, transparency matters.
Patients should provide their complete medication and supplement list rather than assuming that something sold as a wellness product is automatically irrelevant to HBOT.
7. Ozone Therapy: Don’t Manage It as an Automatic Alternative or Add-On
Ozone therapy and HBOT are sometimes discussed together because both involve oxygen-related concepts.
But they are very different modalities.
HBOT involves breathing medical oxygen under increased pressure in a chamber. Ozone involves a reactive form of oxygen and is delivered using completely different methods.
That does not mean that someone can simply combine the two because they both involve oxygen.
The appropriate question is whether there is a clinically justified reason to use both and, if so, how they should be sequenced.
Ozone should never be introduced into an HBOT chamber unless the chamber manufacturer, facility protocols, and qualified medical leadership specifically permit the application.
The oxygen-rich environment already requires strict fire prevention measures. The FDA has recently highlighted serious safety incidents associated with HBOT devices and reinforced the importance of following manufacturer instructions and maintaining appropriate fire safety procedures.
The Most Important Rule: Don’t Bring Unapproved Equipment Into the Chamber
This may be the most important takeaway for anyone operating an HBOT clinic.
A therapy can be perfectly acceptable outside the chamber and still be inappropriate inside it.
That includes:
- Phones
- Tablets
- Electronic devices
- Heating devices
- Electrical equipment
- Certain cosmetics
- Certain creams or products
- Synthetic clothing
- Unapproved monitoring equipment
- Unapproved therapy devices
The FDA recommends using hyperbaric-compatible clothing and following manufacturer instructions regarding prohibited items and static-generating materials.
UHMS likewise emphasizes that decisions about materials, devices, and products entering a chamber must be handled through the facility’s safety process.
This is not an area where guessing is appropriate.
Sequencing May Be Better Than Stacking
One of the biggest misconceptions about combination therapy is that everything needs to happen at the same time.
It doesn’t.
Sometimes the best approach is simply to separate therapies.
For example, a clinic may structure a patient’s schedule so that HBOT occurs in one session and red light, PEMF, hydrogen, IV therapy, or another modality occurs before or afterward.
This creates a more controlled environment and makes it easier to understand how the patient responds to each intervention.
It also makes troubleshooting easier.
If a person develops an unexpected symptom after five therapies performed simultaneously, determining which intervention contributed becomes difficult.
When therapies are separated, the practitioner has a clearer picture of what is happening.
What About “Synergy”?
There is a lot of discussion around therapeutic synergy.
The concept is appealing: if HBOT affects oxygen availability, red light affects cellular signaling, PEMF affects electromagnetic signaling, and another modality influences a different pathway, perhaps combining them produces a stronger overall response.
That possibility can be interesting to explore.
But synergy should be demonstrated rather than assumed.
A biological mechanism that sounds complementary does not automatically mean that combining two interventions produces a better clinical outcome.
This is particularly important when the interventions have different safety profiles.
The goal should always be to balance potential benefits with safety, evidence, timing, and individual patient factors.
A Safer Approach to Combination Therapy
If you’re a patient, talk with your healthcare provider and your hyperbaric team about everything you are taking and every therapy you are using.
If you’re a practitioner, establish written protocols for combination therapies.
Your protocol should address:
- Which therapies may be performed on the same day as HBOT
- Which therapies should be separated by a specific period
- Which devices are approved for chamber use
- Which medications require additional review
- Which products are prohibited inside the chamber
- Who is responsible for approving equipment
- What to do when a new device or therapy is introduced
The hyperbaric physician and safety leadership should have the final say on chamber compatibility and patient-specific considerations.
This is particularly important because HBOT involves elevated oxygen concentrations and pressure, creating a specialized environment that requires dedicated safety procedures. UHMS identifies hyperbaric oxygen as a medical procedure requiring appropriate physician oversight and compliant equipment and facilities.
The Bottom Line
You don’t necessarily need to choose between HBOT and other wellness technologies.
In many cases, therapies such as hydrogen, IV therapy, red light, PEMF, and other modalities may be incorporated into a broader wellness plan.
The mistake is assuming that because two therapies can be used during the same overall program, they should automatically be performed simultaneously.
Sometimes the best strategy is to separate them.
And when it comes to the chamber itself, the rules are even more important.
Never bring a device, product, medication, or material into a hyperbaric chamber simply because it is safe in an ordinary environment. Chamber compatibility needs to be specifically evaluated according to the equipment manufacturer’s instructions and the facility’s hyperbaric safety procedures.
The FDA’s current safety recommendations reinforce this principle, including proper staff training, continuous patient supervision, fire prevention, grounding, maintenance, and control of items entering the chamber.
HBOT can be part of a broader wellness strategy, but good combination therapy is not about doing everything at once.
It’s about doing the right things, at the right time, in the right environment.
For practitioners, that means having clear protocols and a strong safety culture.
For patients, it means telling your provider about every medication, supplement, device, and therapy you use.
And for everyone using HBOT, the safest approach is to respect the chamber for what it is: a specialized oxygen and pressure environment where safety must come first.
Learn More About HBOT Safety
If you are new to hyperbaric oxygen therapy or operate an HBOT clinic, proper education is essential. HBOT USA offers educational resources and training designed to help practitioners better understand HBOT and its safe application.
For clinic owners and practitioners, a safety and compliance checklist can also help identify important areas that should be reviewed before and during chamber operations.
Always work with qualified professionals, follow your chamber manufacturer’s instructions, and use established hyperbaric safety procedures when determining whether another therapy, device, medication, or product can be used before, after, or inside the chamber.
Medical Disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or individualized recommendations. The therapies discussed may have different risks, indications, contraindications, and regulatory considerations. Combining therapies should be discussed with an appropriately qualified healthcare professional and the hyperbaric medical team. Never place a device, medication, product, or other material inside a hyperbaric chamber unless its use has been specifically evaluated and approved for that chamber and protocol.



